Global Radioligand Therapy (RLT) Market: Growth Drivers, Opportunities & Forecast 2035
North America and Europe anchor the global Radioligand Therapy (RLT) Market, collectively representing approximately 75% of total revenue. North America commanded over 45% share in 2024, generating around USD 3.7 billion, supported by advanced healthcare infrastructure and FDA expedited approvals. Europe follows with roughly 30% share and USD 2.44 billion in revenue, performing approximately 10...
0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр
Comunidad EDUCA https://comunidadeduca.com